Revenue Estimates Analysis of Editas Medicine, Inc.(NASDAQ:EDIT): Ciena Corporation(NYSE:CIEN)

0
5

Editas Medicine, Inc. (EDIT) will report its next earnings on Feb 28 AMC. The company reported the earnings of $-0.32/Share in the last quarter where the estimated EPS by analysts was $-0.66/share. The difference between the expected and actual EPS was $0.34/share, which represents an Earnings surprise of 51.5%.

Many analysts are providing their Estimated Earnings analysis for Editas Medicine, Inc. and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

In case of Revenue Estimates, 5 analysts have provided their consensus Average Revenue Estimates for Editas Medicine, Inc. as 18.7 Million. According to these analysts, the Low Revenue Estimate for Editas Medicine, Inc. is 1.5 Million and the High Revenue Estimate is 32 Million. The company had Year Ago Sales of 3.67 Million.

Some buy side analysts are also providing their Analysis on Editas Medicine, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Editas Medicine, Inc. might touch $55 high while the Average Price Target and Low price Target is $41.14 and $30 respectively.

Editas Medicine, Inc. closed its last trading session at $24.22 with the loss of -1.16%. The Market Capitalization of the company stands at 1.19 Billion. The Company has 52-week high of $41.99 and 52-week low of $17.80. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 10.07% where SMA50 and SMA200 are 7% and -17.25% respectively. The Company Touched its 52-Week High on 06/21/18 and 52-Week Low on 12/24/18.

The Relative Volume of the company is 0.47 and Average Volume (3 months) is 1.08 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -27.4%. The Return on Equity (ROE) value stands at -46.8%. While it’s Return on Investment (ROI) value is -42.3%.

While looking at the Stock’s Performance, Editas Medicine, Inc. currently shows a Weekly Performance of 4.72%, where Monthly Performance is 17.99%, Quarterly performance is -19.12%, 6 Months performance is -25.74% and yearly performance percentage is -42.2%. Year to Date performance value (YTD perf) value is 5.23%. The Stock currently has a Weekly Volatility of 4.27% and Monthly Volatility of 5.27%.

Ciena Corporation (CIEN) will report its next earnings on Mar 05 BMO. The company reported the earnings of $0.33/Share in the last quarter where the estimated EPS by analysts was $0.3/share. The difference between the expected and actual EPS was $0.03/share, which represents an Earnings surprise of 10%.

Many analysts are providing their Estimated Earnings analysis for Ciena Corporation and for the current quarter 20 analysts have projected that the stock could give an Average Earnings estimate of $0.41/share. These analysts have also projected a Low Estimate of $0.35/share and a High Estimate of $0.43/share.

In case of Revenue Estimates, 18 analysts have provided their consensus Average Revenue Estimates for Ciena Corporation as 820.09 Million. According to these analysts, the Low Revenue Estimate for Ciena Corporation is 808.1 Million and the High Revenue Estimate is 828.42 Million. The company had Year Ago Sales of 729.98 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for CIEN to be 73.9%. They are projecting Next Quarter growth of 2.08%. For the next 5 years, Ciena Corporation is expecting Growth of 25.22% per annum, whereas in the past 5 years the growth was 29.5% per annum.

Some buy side analysts are also providing their Analysis on Ciena Corporation, where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Ciena Corporation might touch $51 high while the Average Price Target and Low price Target is $44.53 and $32 respectively.

Ciena Corporation closed its last trading session at $39.43 with the loss of -0.41%. The Market Capitalization of the company stands at 6.09 Billion. The Company has 52-week high of $45.70 and 52-week low of $22.99. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -4.76% where SMA50 and SMA200 are 0.89% and 24.76% respectively. The Company Touched its 52-Week High on 03/05/19 and 52-Week Low on 05/31/18.

The Relative Volume of the company is 0.74 and Average Volume (3 months) is 2.88 million. The company’s P/E (price to earnings) ratio is 29.11 and Forward P/E ratio of 17.08.

The company shows its Return on Assets (ROA) value of 20.9%. The Return on Equity (ROE) value stands at 41.7%. While it’s Return on Investment (ROI) value is 6.8%.

While looking at the Stock’s Performance, Ciena Corporation currently shows a Weekly Performance of 1.5%, where Monthly Performance is 1.11%, Quarterly performance is 24.31%, 6 Months performance is 25.46% and yearly performance percentage is 42.85%. Year to Date performance value (YTD perf) value is 15.81%. The Stock currently has a Weekly Volatility of 2.35% and Monthly Volatility of 2.95%.

SHARE